| scholarly article | Q13442814 |
| P2093 | author name string | Gerard M J Bos | |
| Harry C Schouten | |||
| Ariane Vanclée | |||
| P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
| Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells | Q28378178 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| Immunological tolerance--the liver effect | Q33916653 | ||
| Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. | Q34046823 | ||
| Dendritic cells in transplantation--friend or foe? | Q34241103 | ||
| Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes | Q34396514 | ||
| Pathways of allorecognition: implications for transplantation tolerance | Q34823841 | ||
| Immature, but not inactive: the tolerogenic function of immature dendritic cells | Q34842360 | ||
| Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
| Dendritic cells in immunity and tolerance-do they display opposite functions? | Q35181775 | ||
| Novel immunosuppressants | Q35983613 | ||
| Models of T cell anergy: is there a common molecular mechanism? | Q36366967 | ||
| Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides | Q38309722 | ||
| Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides | Q38338318 | ||
| Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression | Q40402602 | ||
| Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. | Q40647086 | ||
| Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
| Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates | Q40779546 | ||
| Differential effects of corticosteroids during different stages of dendritic cell maturation | Q40887640 | ||
| Glucocorticoids and immune function: unknown dimensions and new frontiers | Q41591663 | ||
| Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
| Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3). | Q44752238 | ||
| Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
| Allogeneic T-cell apoptosis induced by interleukin-10-modified dendritic cells: a mechanism of prolongation of intestine allograft survival? | Q45160820 | ||
| Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model | Q46693820 | ||
| Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells | Q47288081 | ||
| Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival | Q47416460 | ||
| Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. | Q51474550 | ||
| Pretransplant Donor Peripheral Blood Mononuclear Cells Infusion Induces Transplantation Tolerance by Generating Regulatory T Cells | Q57702909 | ||
| Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo | Q59312658 | ||
| Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2 | Q64380678 | ||
| Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice | Q71563740 | ||
| Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival | Q73289641 | ||
| Immunity or tolerance: opposite outcomes of microchimerism from skin grafts | Q73339904 | ||
| Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway | Q73763462 | ||
| Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival | Q74015557 | ||
| Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts | Q77373891 | ||
| Transplantation of megadoses of purified haploidentical stem cells | Q77891866 | ||
| P433 | issue | 1 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 8-13 | |
| P577 | publication date | 2006-04-04 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Murine dendritic cells that are resistant to maturation are unable to induce tolerance to allogeneic stem cells | |
| P478 | volume | 16 |
| Q37773272 | Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation |
| Q81549079 | Myeloid differentiation factor 88-silenced bone marrow-derived dendritic cells exhibit enhanced tolerogenicity in intestinal transplantation in rats |
Search more.